<p>Human PRP samples were pre-incubated with PJ34 or its vehicle and then stimulated with either collagen (1 to 2 µg/ml) or PAR1ap (1 to 2 µM). Results are expressed relatively to platelet agonist alone ( = vehicle group; normalized to 100%) and presented as the mean ± SD (n = 7–8).</p
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Platelet aggregometry assays are generally used for the analysis of platelet function but can also b...
BACKGROUND: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have b...
<p>(A) ADP concentration (1.5 to 5 µM) was determined for each donor to produce a biphasic aggregati...
<p>Human PRP samples were pre-incubated with PARP inhibitor (50 µM) or its vehicle and then stimulat...
<p>Human PRP samples were pre-incubated with PJ34 or its vehicle and then stimulated with ADP. Resul...
<p>(A) PL and structural derivatives compound 1 (C1) and compound 2 (C2). (B) PRP was incubated with...
study investigated on human blood the potential antiplatelet effect of PJ34 and two structurally di...
<p>A, ADP or B, collagen was added to platelet-rich plasma, prepared from murine blood drawn at 30 m...
<p>Human PRP and gel-filtered platelets were pre-incubated with control buffer (black), 0.5 µM Dp-3-...
<p>(A) Platelets were induced to aggregate by 5 μg/ml of collagen in the presence of increasing conc...
<p>Washed platelets were preincubated with PBS or losartan (22 μM) for 10 min at 37°C. Buffer or TRA...
Background: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have b...
CXCL12, also known as stromal cell-derived factor-1, is a chemokine classified into CXC families, wh...
<p>Effect of 100 nM of 2MeSADP on platelet aggregation in isolated platelets from untreated animals,...
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Platelet aggregometry assays are generally used for the analysis of platelet function but can also b...
BACKGROUND: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have b...
<p>(A) ADP concentration (1.5 to 5 µM) was determined for each donor to produce a biphasic aggregati...
<p>Human PRP samples were pre-incubated with PARP inhibitor (50 µM) or its vehicle and then stimulat...
<p>Human PRP samples were pre-incubated with PJ34 or its vehicle and then stimulated with ADP. Resul...
<p>(A) PL and structural derivatives compound 1 (C1) and compound 2 (C2). (B) PRP was incubated with...
study investigated on human blood the potential antiplatelet effect of PJ34 and two structurally di...
<p>A, ADP or B, collagen was added to platelet-rich plasma, prepared from murine blood drawn at 30 m...
<p>Human PRP and gel-filtered platelets were pre-incubated with control buffer (black), 0.5 µM Dp-3-...
<p>(A) Platelets were induced to aggregate by 5 μg/ml of collagen in the presence of increasing conc...
<p>Washed platelets were preincubated with PBS or losartan (22 μM) for 10 min at 37°C. Buffer or TRA...
Background: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have b...
CXCL12, also known as stromal cell-derived factor-1, is a chemokine classified into CXC families, wh...
<p>Effect of 100 nM of 2MeSADP on platelet aggregation in isolated platelets from untreated animals,...
<p>Washed human platelets were preincubated with (A) 200 µM A<sub>3</sub>P<sub>5</sub>P or vehicle f...
Platelet aggregometry assays are generally used for the analysis of platelet function but can also b...
BACKGROUND: Neuro- and vasoprotective effects of poly(ADP-ribose)polymerase (PARP) inhibition have b...